Latest Breaking News On - Ketamine infusions centers of texas - Page 1 : comparemela.com

COMP SERVICES (CMPS), CURALEAF HLDGS INC by Curaleaf Hldgs Inc (CURLF), FIELD TRIP HEALTH LTD by Field Trip Health Ltd (FTRPF), JUSHI HLDGS INC CL B by Jushi Holdings Inc (JUSHF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

COMP SERVICES (CMPS), CURALEAF HLDGS INC by Curaleaf Hldgs Inc (CURLF), FIELD TRIP HEALTH LTD by Field Trip Health Ltd (FTRPF), JUSHI HLDGS INC CL B by Jushi Holdings Inc (JUSHF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesWaynej rileyDownstate health sciences universityCompany alsoJushi holdingsUniversity of new yorkInstitutional shareholder servicesUniversity hospital basel liechti labKetamine infusions centers of texasEvolution of mental health medicinesBus business developmentField trip healthCannabis countdownLegal marijuana industryNumber one curated weekly news

Core One Labs Inc : Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy

Core One Labs Inc.: Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FSE:LD62)(WKN:A2P8K3) (the Company ) is pleased to announce that in collaboration with Ketamine Infusions Centers of Texas LLC (KICT) it is exploring a development program for N-dimethyltryptamine (DMT) assisted psychotherapy to address anxiety and depression. In December 2020, the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom (UK) approved the world s first clinical trial testing the efficacy and safety of DMT as a treatment for depression. The first phase of the study (Phase I) commenced in January 2021, with proof of concept Phase IIa expected to follow shortly thereafter. The trial is being conducted by Small Pharma Ltd., a neuropharmaceutical company, working in collaboration with the Centre for Psychedelic Research at Imperial College London

United statesUnited kingdomCosta ricaBritish columbiaCity ofBufo alvariusJoel shackerSmall pharma ltdCore one labs incCanadian securities exchangeHealth canadaKetamine infusions centers of texasHealthcare products regulatory agencyCore one labsKetamine infusions centersPsychedelic research

Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy

Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCosta ricaBritish columbiaCity ofBufo alvariusJoel shackerSmall pharma ltdCore one labs incCanadian securities exchangeHealth canadaKetamine infusions centers of texasHealthcare products regulatory agencyCore one labsKetamine infusions centersPsychedelic research

Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy

Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.